| pubmed-article:2847783 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2847783 | lifeskim:mentions | umls-concept:C0006685 | lld:lifeskim |
| pubmed-article:2847783 | lifeskim:mentions | umls-concept:C0030956 | lld:lifeskim |
| pubmed-article:2847783 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:2847783 | lifeskim:mentions | umls-concept:C1519063 | lld:lifeskim |
| pubmed-article:2847783 | lifeskim:mentions | umls-concept:C0439064 | lld:lifeskim |
| pubmed-article:2847783 | pubmed:issue | 16 | lld:pubmed |
| pubmed-article:2847783 | pubmed:dateCreated | 1989-1-9 | lld:pubmed |
| pubmed-article:2847783 | pubmed:abstractText | Evidence from electrophysiological and ion flux studies has established that dihydropyridine-sensitive calcium channels are subject to regulation by neurotransmitter-mediated phosphorylation and dephosphorylation reactions. In the present study, we have further characterized the phosphorylation by cAMP-dependent protein kinase and a multifunctional Ca/calmodulin-dependent protein kinase of the membrane-associated form of the 165-kDa polypeptide identified as the skeletal muscle dihydropyridine receptor. The initial rates of phosphorylation of the 165-kDa peptide by both protein kinases were found to be relatively good compared to the rates of phosphorylation of established substrates of the enzymes. Phosphorylation of the 165-kDa peptide by both protein kinases was additive. Prior phosphorylation by either one of the kinases alone did not preclude phosphorylation by the second kinase. The cAMP-dependent protein kinase phosphorylated the 165-kDa peptide preferentially at serine residues, although a small amount of phosphothreonine was also formed. In contrast, after phosphorylation of the 165-kDa peptide by the Ca/calmodulin-dependent protein kinase, slightly more phosphothreonine than phosphoserine was recovered. Phosphopeptide mapping indicated that the two kinases phosphorylated the peptide at distinct as well as similar sites. Notably, one major site phosphorylated by the cAMP-dependent protein kinase was not phosphorylated by the Ca/calmodulin-dependent protein kinase, while other sites were phosphorylated to a high degree by the Ca/calmodulin-dependent protein kinase, but to a much lesser degree by the cAMP-dependent protein kinase. The results show that the 165-kDa dihydropyridine receptor from skeletal muscle can be multiply phosphorylated at distinct sites by the cAMP- and Ca/calmodulin-dependent protein kinases. As the 165-kDa peptide may be the major functional unit of the dihydropyridine-sensitive Ca channel, the results suggest that the phosphorylation-dependent modulation of Ca channel activity by neurotransmitters may involve phosphorylation of the 165-kDa peptide at multiple sites. | lld:pubmed |
| pubmed-article:2847783 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2847783 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2847783 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2847783 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2847783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2847783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2847783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2847783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2847783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2847783 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2847783 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:2847783 | pubmed:issn | 0006-2960 | lld:pubmed |
| pubmed-article:2847783 | pubmed:author | pubmed-author:HoseyM MMM | lld:pubmed |
| pubmed-article:2847783 | pubmed:author | pubmed-author:O'CallahanC... | lld:pubmed |
| pubmed-article:2847783 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2847783 | pubmed:day | 9 | lld:pubmed |
| pubmed-article:2847783 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:2847783 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2847783 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2847783 | pubmed:pagination | 6071-7 | lld:pubmed |
| pubmed-article:2847783 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:2847783 | pubmed:meshHeading | pubmed-meshheading:2847783-... | lld:pubmed |
| pubmed-article:2847783 | pubmed:meshHeading | pubmed-meshheading:2847783-... | lld:pubmed |
| pubmed-article:2847783 | pubmed:meshHeading | pubmed-meshheading:2847783-... | lld:pubmed |
| pubmed-article:2847783 | pubmed:meshHeading | pubmed-meshheading:2847783-... | lld:pubmed |
| pubmed-article:2847783 | pubmed:meshHeading | pubmed-meshheading:2847783-... | lld:pubmed |
| pubmed-article:2847783 | pubmed:meshHeading | pubmed-meshheading:2847783-... | lld:pubmed |
| pubmed-article:2847783 | pubmed:meshHeading | pubmed-meshheading:2847783-... | lld:pubmed |
| pubmed-article:2847783 | pubmed:meshHeading | pubmed-meshheading:2847783-... | lld:pubmed |
| pubmed-article:2847783 | pubmed:meshHeading | pubmed-meshheading:2847783-... | lld:pubmed |
| pubmed-article:2847783 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:2847783 | pubmed:articleTitle | Multiple phosphorylation sites in the 165-kilodalton peptide associated with dihydropyridine-sensitive calcium channels. | lld:pubmed |
| pubmed-article:2847783 | pubmed:affiliation | Department of Biological Chemistry and Structure, University of Health Sciences, Chicago Medical School, Illinois 60064. | lld:pubmed |
| pubmed-article:2847783 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2847783 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:2847783 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:2847783 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2847783 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2847783 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2847783 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2847783 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2847783 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2847783 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2847783 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2847783 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2847783 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2847783 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2847783 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2847783 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2847783 | lld:pubmed |
